abstract |
Proteins having antibody heavy and light chain variable domains capable of pairing to form an antigen-binding site targeting FLT3 on a cell, pharmaceutical compositions comprising such proteins, and such proteins and pharmaceutical compositions, including those for the treatment of cancer A treatment method using |